Aqua Bio Technology hopes new products will drive sales growth


Aquabeautine XL supplier experiences \'volatile\' revenue stream in 2012

Norway’s Aqua Bio Technology has reported a fall in revenue in the second quarter of 2012. The company posted a significant sales increase in the first quarter of the year when two major contracts boosted income to NOK11.9m. However, second quarter income was just NOK0.1m, compared with NOK0.4m in the same period of 2011.

The company, which is responsible for Aquabeautine XL, an anti-ageing skin care ingredient derived from the hatching fluid of salmon, reported sales of NOK12.1m in the first half of the year, a considerable increase compared with sales of NOK0.4m in the prior year period.

“Aqua Bio Technology is still in a build-up phase and our revenue stream will remain volatile for some time, reflecting that new contracts may have significant impact at the time they materialise,” said ABT’s ceo Arvid Lindberg.

Sign up for your free email newsletter

The company expects the launch of three new products in September will boost income in the second half of 2012. The products will be launched ahead of schedule – the result of accelerated product development in the second quarter. And based on the current order backlog, ABT forecasts significant sales growth in the second half of 2012 and in coming years.